In Depth Research on Global Transdermal Patch Market and Clinical Pipeline Outlook 2022

“Global Transdermal Patch Market and Clinical Pipeline Outlook 2022” report highlights:

* Introduction and Classification of Transdermal Patch
* Mechanism of Transdermal Patch Drug Delivery
* Transdermal Patch v/s Traditional Drug Delivery Methods
* Global Transdermal Patch Clinical Pipeline Overview
* Marketed Transdermal Patch Clinical Insight by Company, Indication and Phase
* Global Transdermal Patch Market Future Prospects

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-global-transdermal-patch-market-and-clinical-pipeline-outlook-2022.php

Table of Contents

Introduction to Transdermal Patch

Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch

Why There Exist Need for Transdermal Patches?

Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of Transdermal Patch
4.3 Mechanism of Motion Sickness, Nicotine and Female Contraceptive Transdermal Patch

Transdermal Patch v/s Traditional Drug Delivery Methods

Global Transdermal Patch Market Outlook
6.1 Global Market Scenario
6.2 Regional Trends

Global Transdermal Patch Clinical Pipeline Overview
7.1 By Phase
7.2 By Region/Country
7.3 By Drug Class/Molecule
7.4 By Company
7.5 By Orphan and Fast Track Status
7.6 By Mode of Action

Global Transdermal Patch Market Dynamics
8.1 Favorable Market Parameters
8.2 Commercialization Challenges

Global Transdermal Patch Market Future Prospects

Global Transdermal Patch Clinical Insight
10.1 Unknown
10.2 Research
10.3 Preclinical
10.4 Clinical
10.5 Phase-I
10.6 Phase-I/II
10.7 Phase-II
10.8 Phase-II/III
10.9 Phase-III
10.10 Preregistration
10.11 Registered

Marketed Transdermal Patch Clinical Insight by Company, Indication and Phase

Competitive Landscape
12.1 3M Pharmaceuticals
12.2 Acrux
12.3 Agile Therapeutics
12.4 Allergan
12.5 ANI Pharmaceuticals
12.6 Antares Pharma
12.7 Bayer HealthCare Pharmaceuticals
12.8 Corium International
12.9 Chase Pharmaceuticals
12.10 DURECT Corporation
12.11 Endo Pharmaceuticals
12.12 Fempharm
12.13 Hisamitsu Pharmaceutical
12.14 Immune Pharmaceuticals
12.15 Imprimis Pharmaceuticals
12.16 Ipsen Bioscience
12.17 Johnson and Johnson
12.18 LaSalle Laboratories
12.19 Lavipharm-increase
12.20 MINRAD International
12.21 NeurogesX
12.22 Noven Pharmaceuticals
12.23 NuPathe
12.24 Nuvo Research
12.25 Novartis
12.26 Pain Therapeutics
12.27 ProStrakan
12.28 Purdue Pharma
12.29 Sanofi
12.30 Scilex Pharmaceuticals
12.31 Senju Pharmaceutical
12.32 Somerset Pharmaceuticals
12.33 Teikoku Seiyaku
12.34 Therapeutic Discovery Corporation
12.35 Transdermal Delivery Solutions Corp
12.36 UCB-full form
12.37 Xel Pharmaceuticals
12.38 Zosano Pharma

Figure 1-1: Steps Involved in Transdermal Permeation
Figure 1-2: Ideal Properties of Transdermal Patch
Figure 2-1: Types of Commercially Available Transdermal Patch
Figure 4-1: Properties of Transdermal Therapeutics
Figure 4-2: Components of Transdermal Patch
Figure 4-3: Types of Permeation Enhancers
Figure 4-4: Schematic Representation of Iontophoresis
Figure 4-5: Mechanism of Scopolamine Transdermal Patch
Figure 4-6: Mechanism of Nicotine Transdermal Patch
Figure 4-7: Mechanism of Female Contraceptive Transdermal Patch
Figure 5-1: Issues with Traditional Drug Delivery Methods
Figure 5-2: Advantages of Transdermal Patch
Figure 5-3: Consistent Drug Supply by Transdermal Patch
Figure 6-1: Global andndash; Transdermal Patch Market Opportunity (US$ Billion), 2016-2022
Figure 7-1: Global andndash; Transdermal Patch Pipeline by Phase (%), 2017 till 2022
Figure 7-2: Global andndash; Transdermal Patch Pipeline by Phase (Number), 2017 till 2022
Figure 7-3: Global andndash; Transdermal Patch Pipeline by Phase (%), 2017 till 2022
Figure 7-4: Global andndash; Transdermal Patch Pipeline by Phase (Number), 2017 till 2022
Figure 7-5: Global - Transdermal Patch Pipeline by Region (%), 2017 till 2022
Figure 7-6: Global - Transdermal Patch Pipeline by Country (%), 2017 till 2022
Figure 7-7: Global - Transdermal Patch Pipeline by Drug Class/Molecule (%), 2017 till 2022
Figure 7-8: Global - Transdermal Patch Pipeline by Company (%), 2017 till 2022
Figure 7-9: Global - Transdermal Patch Pipeline by Ophan and Fast Track Status (%), 2017 till 2022
Figure 7-10: Global - Transdermal Patch Pipeline by Mode of Action (%), 2017 till 2022
Figure 8-1: Drivers for Transdermal Patch
Figure 8-2: Transdermal Patch Market Commercialization Challenges
Figure 12-1: Acrux Clinical Pipeline
Figure 12-2: Agile Therapeutics Clinical Pipeline
Figure 12-3: Antares Pharma Clinical Pipeline
Figure 12-4: Corium International Clinical Pipeline
Figure 12-5: Durect Corporation Clinical Pipeline
Figure 12-6: Endo Pharmaceuticals Clinical Pipeline
Figure 12-7: Immune Pharmaceuticals Clinical Pipeline
Figure 12-8: Novartis Clinical Pipeline
Figure 12-9: Senju Pharmaceuticals Clinical Pipeline
Figure 12-10: Xel Pharamaceuticals Clinical Pipeline
Figure 12-11: Zosano Pharma Clinical Pipeline


Table 2-1: Differences between Active and Passive Transdermal Patches
Table 4-1: Transdermal Patches for Various Disease Indications
Table 12-1: Pain Therapeutics Clinical Pipeline

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.